

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.65926563 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.62891447 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.62891447 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.62891447 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.62891447 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.62891447 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.62891447 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.48649779 |
| 9 | positive regulation of interferon-alpha production (GO:0032727) | 4.39459185 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.26824823 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 4.20179784 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 3.94493813 |
| 13 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.87718733 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.77741331 |
| 15 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.67059497 |
| 16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.63652011 |
| 17 | response to host immune response (GO:0052572) | 3.63652011 |
| 18 | response to peptidoglycan (GO:0032494) | 3.58449248 |
| 19 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.45184822 |
| 20 | natural killer cell mediated immunity (GO:0002228) | 3.45184822 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.41258409 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.41258409 |
| 23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.40813168 |
| 24 | response to host (GO:0075136) | 3.40813168 |
| 25 | response to host defenses (GO:0052200) | 3.40813168 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.39246320 |
| 27 | response to muramyl dipeptide (GO:0032495) | 3.30382902 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.29627658 |
| 29 | regulation of cholesterol storage (GO:0010885) | 3.27740335 |
| 30 | T cell migration (GO:0072678) | 3.27119192 |
| 31 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.26066923 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.26047765 |
| 33 | tolerance induction (GO:0002507) | 3.24026926 |
| 34 | cell adhesion mediated by integrin (GO:0033627) | 3.20795482 |
| 35 | negative thymic T cell selection (GO:0045060) | 3.20608435 |
| 36 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.20571088 |
| 37 | negative T cell selection (GO:0043383) | 3.18778101 |
| 38 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.17492558 |
| 39 | positive regulation of interferon-beta production (GO:0032728) | 3.16708697 |
| 40 | regulation of T cell tolerance induction (GO:0002664) | 3.14965074 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.14105171 |
| 42 | I-kappaB phosphorylation (GO:0007252) | 3.11395333 |
| 43 | low-density lipoprotein particle clearance (GO:0034383) | 3.11026889 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.08432259 |
| 45 | detection of other organism (GO:0098543) | 3.07263697 |
| 46 | granulocyte activation (GO:0036230) | 3.07006529 |
| 47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04105917 |
| 48 | negative regulation of lipid storage (GO:0010888) | 3.02502390 |
| 49 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.01501848 |
| 50 | response to interferon-alpha (GO:0035455) | 3.00343251 |
| 51 | response to type I interferon (GO:0034340) | 2.98711482 |
| 52 | regulation of tolerance induction (GO:0002643) | 2.97132849 |
| 53 | type I interferon signaling pathway (GO:0060337) | 2.96985165 |
| 54 | cellular response to type I interferon (GO:0071357) | 2.96985165 |
| 55 | regulation of mononuclear cell migration (GO:0071675) | 2.95911318 |
| 56 | microglial cell activation (GO:0001774) | 2.95473332 |
| 57 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.94929441 |
| 58 | neutrophil activation (GO:0042119) | 2.92862422 |
| 59 | pinocytosis (GO:0006907) | 2.92500008 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91250370 |
| 61 | cellular extravasation (GO:0045123) | 2.90730387 |
| 62 | detection of molecule of bacterial origin (GO:0032490) | 2.90454892 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 2.90351089 |
| 64 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89591934 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 2.88269775 |
| 66 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88222349 |
| 67 | interferon-gamma production (GO:0032609) | 2.86502268 |
| 68 | detection of bacterium (GO:0016045) | 2.85846189 |
| 69 | cellular response to interferon-alpha (GO:0035457) | 2.85016391 |
| 70 | apoptotic cell clearance (GO:0043277) | 2.83940220 |
| 71 | macrophage activation (GO:0042116) | 2.83711608 |
| 72 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.83614827 |
| 73 | positive thymic T cell selection (GO:0045059) | 2.83240320 |
| 74 | detection of external biotic stimulus (GO:0098581) | 2.81028598 |
| 75 | response to interleukin-15 (GO:0070672) | 2.80978953 |
| 76 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.78808846 |
| 77 | positive regulation of p38MAPK cascade (GO:1900745) | 2.76704245 |
| 78 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.76445710 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 2.75758638 |
| 80 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.75700970 |
| 81 | positive regulation of tolerance induction (GO:0002645) | 2.75329094 |
| 82 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.75232400 |
| 83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74244865 |
| 84 | NIK/NF-kappaB signaling (GO:0038061) | 2.73886616 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72782011 |
| 86 | B cell homeostasis (GO:0001782) | 2.72751080 |
| 87 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.72234286 |
| 88 | positive regulation of interleukin-12 production (GO:0032735) | 2.71396465 |
| 89 | regulation of macrophage cytokine production (GO:0010935) | 2.70358001 |
| 90 | positive regulation of heat generation (GO:0031652) | 2.69792759 |
| 91 | regulation of gamma-delta T cell activation (GO:0046643) | 2.69440315 |
| 92 | respiratory burst (GO:0045730) | 2.69433267 |
| 93 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.67300983 |
| 94 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.66343219 |
| 95 | negative regulation of cell killing (GO:0031342) | 2.66343219 |
| 96 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.66322783 |
| 97 | regulation of necroptotic process (GO:0060544) | 2.64975894 |
| 98 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.63242429 |
| 99 | response to protozoan (GO:0001562) | 2.63033931 |
| 100 | myeloid dendritic cell differentiation (GO:0043011) | 2.62902625 |
| 101 | regulation of B cell differentiation (GO:0045577) | 2.61835978 |
| 102 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.61718873 |
| 103 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.60684514 |
| 104 | T cell costimulation (GO:0031295) | 2.59526390 |
| 105 | T cell selection (GO:0045058) | 2.58745207 |
| 106 | positive regulation of macrophage cytokine production (GO:0060907) | 2.57891400 |
| 107 | cytokine secretion (GO:0050663) | 2.57555987 |
| 108 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.57191450 |
| 109 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.56912360 |
| 110 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.56584797 |
| 111 | regulation of antigen processing and presentation (GO:0002577) | 2.55490797 |
| 112 | lymphocyte costimulation (GO:0031294) | 2.55115707 |
| 113 | defense response to protozoan (GO:0042832) | 2.54790751 |
| 114 | thymic T cell selection (GO:0045061) | 2.54599587 |
| 115 | positive regulation of lipid storage (GO:0010884) | 2.54578554 |
| 116 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.54302689 |
| 117 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.53898896 |
| 118 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.53898896 |
| 119 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.53890694 |
| 120 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.53184204 |
| 121 | cellular response to interleukin-15 (GO:0071350) | 2.52288474 |
| 122 | monocyte chemotaxis (GO:0002548) | 2.52230019 |
| 123 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.51955822 |
| 124 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.51753723 |
| 125 | positive T cell selection (GO:0043368) | 2.51745338 |
| 126 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.51414984 |
| 127 | myeloid dendritic cell activation (GO:0001773) | 2.50440052 |
| 128 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.50168349 |
| 129 | positive regulation of B cell proliferation (GO:0030890) | 2.50128324 |
| 130 | T-helper 1 type immune response (GO:0042088) | 2.49992891 |
| 131 | positive regulation of interleukin-2 production (GO:0032743) | 2.49131485 |
| 132 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.48714173 |
| 133 | positive regulation of B cell differentiation (GO:0045579) | 2.48710512 |
| 134 | membrane raft organization (GO:0031579) | 2.48696338 |
| 135 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.48554675 |
| 136 | B cell mediated immunity (GO:0019724) | 2.48317413 |
| 137 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.47536655 |
| 138 | B cell proliferation (GO:0042100) | 2.47399047 |
| 139 | regulation of interleukin-12 production (GO:0032655) | 2.47071268 |
| 140 | regulation of integrin activation (GO:0033623) | 2.46820954 |
| 141 | T cell homeostasis (GO:0043029) | 2.45690018 |
| 142 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.44988162 |
| 143 | wound healing, spreading of epidermal cells (GO:0035313) | 2.44553041 |
| 144 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.43020608 |
| 145 | cellular response to virus (GO:0098586) | 2.42460209 |
| 146 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.42045735 |
| 147 | negative regulation of interleukin-17 production (GO:0032700) | 2.38860651 |
| 148 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.38447590 |
| 149 | germinal center formation (GO:0002467) | 2.37900034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.72480426 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.14883066 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.12637657 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.26192752 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.63816043 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.57561534 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.53324353 |
| 8 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.33949541 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.31455992 |
| 10 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.20642769 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.15228733 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.09285092 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.91911773 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.91119326 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73654396 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70436524 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.65993767 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.36559624 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.23505495 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.17736529 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16823428 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08662212 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00895536 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89811690 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87765589 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.80434399 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.77740608 |
| 28 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75303827 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.74952066 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74238673 |
| 31 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73313711 |
| 32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70199360 |
| 33 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.68061624 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.67705911 |
| 35 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.67020048 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.63598277 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.62621269 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.62512786 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61971196 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.59081241 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58395265 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57544537 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57216375 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.54341146 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53692384 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52725141 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51575805 |
| 48 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.51223563 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44984635 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44801523 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42774380 |
| 52 | * MYB_26560356_Chip-Seq_TH1_Human | 1.39730490 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37238746 |
| 54 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35585496 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33358269 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29330964 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.28705921 |
| 58 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28030566 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27460260 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25534934 |
| 61 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24415377 |
| 62 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23760839 |
| 63 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22012165 |
| 64 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20825579 |
| 65 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20825579 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18722819 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17075130 |
| 68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15504625 |
| 69 | * MAF_26560356_Chip-Seq_TH2_Human | 1.12907826 |
| 70 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11581807 |
| 71 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11549425 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10681648 |
| 73 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09538072 |
| 74 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08859338 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08697300 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07830518 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05955001 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05917277 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05893935 |
| 80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05850165 |
| 81 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05481198 |
| 82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04652497 |
| 83 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.03309664 |
| 84 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.03309664 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02819564 |
| 86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02771272 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01965684 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98911411 |
| 89 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98506848 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96318720 |
| 91 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95972419 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95848471 |
| 93 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95532401 |
| 94 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95286122 |
| 95 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95286122 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95090794 |
| 97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94935775 |
| 98 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93275427 |
| 99 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92267963 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91397595 |
| 101 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.89582170 |
| 102 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89422211 |
| 103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88608869 |
| 104 | MYC_22102868_ChIP-Seq_BL_Human | 0.88122788 |
| 105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87741117 |
| 106 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87088944 |
| 107 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86564636 |
| 108 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.86347682 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86294566 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85125663 |
| 111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84455055 |
| 112 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.83312219 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82552145 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81912121 |
| 115 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81337987 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80039656 |
| 117 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.78966844 |
| 118 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78646780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.44225703 |
| 2 | MP0003436_decreased_susceptibility_to | 3.17673111 |
| 3 | MP0003303_peritoneal_inflammation | 2.82337609 |
| 4 | MP0006082_CNS_inflammation | 2.69220659 |
| 5 | MP0009785_altered_susceptibility_to | 2.65923189 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.62563061 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.58634435 |
| 8 | MP0003724_increased_susceptibility_to | 2.51169369 |
| 9 | MP0002419_abnormal_innate_immunity | 2.44609036 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.41889857 |
| 11 | MP0001790_abnormal_immune_system | 2.38580018 |
| 12 | MP0005387_immune_system_phenotype | 2.38580018 |
| 13 | MP0000685_abnormal_immune_system | 2.36865128 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.32169776 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.24700084 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.23524200 |
| 17 | MP0005025_abnormal_response_to | 2.18997293 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.10123857 |
| 19 | MP0001800_abnormal_humoral_immune | 2.04153870 |
| 20 | MP0004510_myositis | 2.00710505 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 2.00569292 |
| 22 | MP0002723_abnormal_immune_serum | 1.93592186 |
| 23 | MP0005671_abnormal_response_to | 1.91344442 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.88543636 |
| 25 | MP0004947_skin_inflammation | 1.83318397 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.77384936 |
| 27 | MP0009840_abnormal_foam_cell | 1.73813090 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.73500584 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.73070393 |
| 30 | MP0003448_altered_tumor_morphology | 1.72751153 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.72242950 |
| 32 | MP0001819_abnormal_immune_cell | 1.71758842 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.69729306 |
| 34 | MP0002405_respiratory_system_inflammati | 1.65021451 |
| 35 | MP0002006_tumorigenesis | 1.57841734 |
| 36 | MP0001853_heart_inflammation | 1.56754601 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.54806317 |
| 38 | MP0009764_decreased_sensitivity_to | 1.53736430 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.53168699 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.53103593 |
| 41 | MP0009278_abnormal_bone_marrow | 1.53076527 |
| 42 | MP0001542_abnormal_bone_strength | 1.52863207 |
| 43 | MP0005503_abnormal_tendon_morphology | 1.52314379 |
| 44 | MP0001958_emphysema | 1.51240714 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.48179188 |
| 46 | MP0000343_altered_response_to | 1.46966306 |
| 47 | MP0008469_abnormal_protein_level | 1.43174776 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.38037236 |
| 49 | MP0002254_reproductive_system_inflammat | 1.36708755 |
| 50 | MP0000858_altered_metastatic_potential | 1.35848626 |
| 51 | MP0005275_abnormal_skin_tensile | 1.35678631 |
| 52 | MP0000604_amyloidosis | 1.27818626 |
| 53 | MP0006054_spinal_hemorrhage | 1.27691303 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 1.27434545 |
| 55 | MP0005257_abnormal_intraocular_pressure | 1.27016318 |
| 56 | MP0002933_joint_inflammation | 1.25437297 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 1.24303928 |
| 58 | MP0003091_abnormal_cell_migration | 1.24284864 |
| 59 | MP0000716_abnormal_immune_system | 1.23165619 |
| 60 | MP0005023_abnormal_wound_healing | 1.21395759 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.17923701 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.17923701 |
| 63 | MP0003075_altered_response_to | 1.16573153 |
| 64 | MP0004883_abnormal_blood_vessel | 1.15481044 |
| 65 | MP0002398_abnormal_bone_marrow | 1.14956874 |
| 66 | MP0005451_abnormal_body_composition | 1.14107572 |
| 67 | MP0003279_aneurysm | 1.13971595 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.13081598 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.11249607 |
| 70 | MP0010307_abnormal_tumor_latency | 1.10872159 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.08946050 |
| 72 | MP0005666_abnormal_adipose_tissue | 1.08488707 |
| 73 | MP0003045_fibrosis | 1.08088444 |
| 74 | MP0005390_skeleton_phenotype | 1.07450255 |
| 75 | MP0008004_abnormal_stomach_pH | 1.07413873 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.06328884 |
| 77 | MP0005083_abnormal_biliary_tract | 1.06017857 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 1.04326393 |
| 79 | MP0009763_increased_sensitivity_to | 1.02906053 |
| 80 | MP0003828_pulmonary_edema | 1.00985867 |
| 81 | MP0005164_abnormal_response_to | 1.00736903 |
| 82 | MP0003950_abnormal_plasma_membrane | 1.00667018 |
| 83 | MP0002429_abnormal_blood_cell | 0.99718989 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.99059830 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.99059326 |
| 86 | MP0000767_abnormal_smooth_muscle | 0.98366603 |
| 87 | MP0002722_abnormal_immune_system | 0.95870845 |
| 88 | MP0005166_decreased_susceptibility_to | 0.95769236 |
| 89 | MP0000703_abnormal_thymus_morphology | 0.95737436 |
| 90 | MP0002971_abnormal_brown_adipose | 0.94169140 |
| 91 | MP0000249_abnormal_blood_vessel | 0.92771927 |
| 92 | MP0000371_diluted_coat_color | 0.91425046 |
| 93 | MP0000609_abnormal_liver_physiology | 0.90431972 |
| 94 | MP0005165_increased_susceptibility_to | 0.90197717 |
| 95 | MP0005375_adipose_tissue_phenotype | 0.89771955 |
| 96 | MP0002139_abnormal_hepatobiliary_system | 0.89193505 |
| 97 | MP0001851_eye_inflammation | 0.88776714 |
| 98 | MP0001873_stomach_inflammation | 0.88380470 |
| 99 | MP0003690_abnormal_glial_cell | 0.87884374 |
| 100 | MP0001879_abnormal_lymphatic_vessel | 0.85504500 |
| 101 | MP0009115_abnormal_fat_cell | 0.85139480 |
| 102 | MP0000465_gastrointestinal_hemorrhage | 0.84804340 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.82688140 |
| 104 | MP0002060_abnormal_skin_morphology | 0.82151893 |
| 105 | MP0001881_abnormal_mammary_gland | 0.81073850 |
| 106 | MP0003763_abnormal_thymus_physiology | 0.80432853 |
| 107 | MP0005360_urolithiasis | 0.80081329 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.80027827 |
| 109 | MP0005174_abnormal_tail_pigmentation | 0.79690098 |
| 110 | MP0002009_preneoplasia | 0.79022657 |
| 111 | MP0001243_abnormal_dermal_layer | 0.78645023 |
| 112 | MP0002396_abnormal_hematopoietic_system | 0.78355271 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.78072403 |
| 114 | MP0005310_abnormal_salivary_gland | 0.77715079 |
| 115 | MP0003795_abnormal_bone_structure | 0.77364283 |
| 116 | MP0004130_abnormal_muscle_cell | 0.76664991 |
| 117 | MP0003252_abnormal_bile_duct | 0.75536262 |
| 118 | MP0000733_abnormal_muscle_development | 0.72924851 |
| 119 | MP0005595_abnormal_vascular_smooth | 0.72037895 |
| 120 | MP0005670_abnormal_white_adipose | 0.71787900 |
| 121 | MP0002133_abnormal_respiratory_system | 0.71641920 |
| 122 | MP0005388_respiratory_system_phenotype | 0.71641920 |
| 123 | MP0010329_abnormal_lipoprotein_level | 0.70184815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.17870400 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.94549711 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.63075573 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.31991469 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 3.91544162 |
| 6 | Myocardial infarction (HP:0001658) | 3.85214082 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.81352470 |
| 8 | Orchitis (HP:0100796) | 3.68272054 |
| 9 | Myositis (HP:0100614) | 3.61407205 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.57683451 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.56316682 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 3.55112029 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.43187354 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.30030828 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.27789052 |
| 16 | Optic neuritis (HP:0100653) | 3.25157370 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.25157370 |
| 18 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.18911495 |
| 19 | Osteolytic defects of the hand bones (HP:0009699) | 3.18911495 |
| 20 | Gingivitis (HP:0000230) | 3.17456218 |
| 21 | Gastrointestinal stroma tumor (HP:0100723) | 3.12195801 |
| 22 | Stomatitis (HP:0010280) | 3.11918593 |
| 23 | Recurrent skin infections (HP:0001581) | 3.06552750 |
| 24 | Spondylolisthesis (HP:0003302) | 3.06142610 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.02925085 |
| 26 | Hematochezia (HP:0002573) | 3.02054172 |
| 27 | Peritonitis (HP:0002586) | 2.98521409 |
| 28 | Recurrent bronchitis (HP:0002837) | 2.95672420 |
| 29 | Periodontitis (HP:0000704) | 2.92732076 |
| 30 | Axonal loss (HP:0003447) | 2.90735405 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 2.86887649 |
| 32 | Vasculitis (HP:0002633) | 2.84158857 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.65675743 |
| 34 | Arterial thrombosis (HP:0004420) | 2.63024290 |
| 35 | Thick nail (HP:0001805) | 2.61038818 |
| 36 | Vertebral compression fractures (HP:0002953) | 2.58144691 |
| 37 | Prostate neoplasm (HP:0100787) | 2.57702901 |
| 38 | Agammaglobulinemia (HP:0004432) | 2.55686128 |
| 39 | Recurrent viral infections (HP:0004429) | 2.54919826 |
| 40 | Gingival bleeding (HP:0000225) | 2.53016669 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.52237566 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.48498442 |
| 43 | Abnormality of T cells (HP:0002843) | 2.46124986 |
| 44 | Disinhibition (HP:0000734) | 2.45889555 |
| 45 | Glomerulonephritis (HP:0000099) | 2.45777038 |
| 46 | Dilatation of the ascending aorta (HP:0005111) | 2.44493444 |
| 47 | Premature rupture of membranes (HP:0001788) | 2.43652582 |
| 48 | Tetraparesis (HP:0002273) | 2.42954333 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.39400128 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.39400128 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.39078633 |
| 52 | IgA deficiency (HP:0002720) | 2.38611898 |
| 53 | Autoimmune hemolytic anemia (HP:0001890) | 2.38024667 |
| 54 | Esophageal varix (HP:0002040) | 2.37876072 |
| 55 | Pustule (HP:0200039) | 2.37051920 |
| 56 | Nephritis (HP:0000123) | 2.36739235 |
| 57 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.36651450 |
| 58 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.36651450 |
| 59 | Abnormality of glycolipid metabolism (HP:0010969) | 2.36651450 |
| 60 | Joint hemorrhage (HP:0005261) | 2.32424521 |
| 61 | Type 1 muscle fiber predominance (HP:0003803) | 2.31819769 |
| 62 | Obstructive lung disease (HP:0006536) | 2.29711476 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29711476 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26932295 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26932295 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26932295 |
| 67 | Basal ganglia calcification (HP:0002135) | 2.26512240 |
| 68 | Osteomyelitis (HP:0002754) | 2.25870314 |
| 69 | Cellulitis (HP:0100658) | 2.25697138 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.25334528 |
| 71 | Recurrent cutaneous fungal infections (HP:0011370) | 2.25334528 |
| 72 | Restrictive lung disease (HP:0002091) | 2.23202867 |
| 73 | Protrusio acetabuli (HP:0003179) | 2.23191029 |
| 74 | B lymphocytopenia (HP:0010976) | 2.21694594 |
| 75 | Spontaneous hematomas (HP:0007420) | 2.17690732 |
| 76 | Leukocytosis (HP:0001974) | 2.17539602 |
| 77 | Cerebral aneurysm (HP:0004944) | 2.17121668 |
| 78 | Loss of speech (HP:0002371) | 2.16986806 |
| 79 | Abnormality of B cell number (HP:0010975) | 2.16913783 |
| 80 | Abnormality of complement system (HP:0005339) | 2.14026896 |
| 81 | Premature loss of primary teeth (HP:0006323) | 2.13983817 |
| 82 | Hemoptysis (HP:0002105) | 2.13837319 |
| 83 | Urticaria (HP:0001025) | 2.13706066 |
| 84 | Vascular tortuosity (HP:0004948) | 2.13505607 |
| 85 | Bone pain (HP:0002653) | 2.11485552 |
| 86 | Complement deficiency (HP:0004431) | 2.10497312 |
| 87 | Gastrointestinal infarctions (HP:0005244) | 2.10070398 |
| 88 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.09876434 |
| 89 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09325207 |
| 90 | Fatigue (HP:0012378) | 2.08209572 |
| 91 | Lymphopenia (HP:0001888) | 2.08070847 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 2.05142553 |
| 93 | Recurrent pneumonia (HP:0006532) | 2.04646751 |
| 94 | Aortic aneurysm (HP:0004942) | 2.03161485 |
| 95 | Recurrent lower respiratory tract infections (HP:0002783) | 2.02619464 |
| 96 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00704926 |
| 97 | Inflammation of the large intestine (HP:0002037) | 2.00408799 |
| 98 | Aortic dissection (HP:0002647) | 1.99020477 |
| 99 | IgG deficiency (HP:0004315) | 1.95654669 |
| 100 | Mitral stenosis (HP:0001718) | 1.95399048 |
| 101 | Pathologic fracture (HP:0002756) | 1.95100708 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 1.94892576 |
| 103 | Hydroxyprolinuria (HP:0003080) | 1.94892576 |
| 104 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.94870750 |
| 105 | Panhypogammaglobulinemia (HP:0003139) | 1.94322976 |
| 106 | Increased IgM level (HP:0003496) | 1.94081210 |
| 107 | Increased IgE level (HP:0003212) | 1.94031029 |
| 108 | Abnormality of T cell number (HP:0011839) | 1.93678077 |
| 109 | Xanthomatosis (HP:0000991) | 1.93035201 |
| 110 | Increased density of long bones (HP:0006392) | 1.92641924 |
| 111 | Persistence of primary teeth (HP:0006335) | 1.92635582 |
| 112 | Arterial tortuosity (HP:0005116) | 1.92023626 |
| 113 | Encephalitis (HP:0002383) | 1.91626205 |
| 114 | Verrucae (HP:0200043) | 1.90895927 |
| 115 | Papilloma (HP:0012740) | 1.90895927 |
| 116 | Cervical subluxation (HP:0003308) | 1.90065090 |
| 117 | Spinal cord lesions (HP:0100561) | 1.89722307 |
| 118 | Syringomyelia (HP:0003396) | 1.89722307 |
| 119 | Absent frontal sinuses (HP:0002688) | 1.89366129 |
| 120 | Acrocyanosis (HP:0001063) | 1.89060020 |
| 121 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88574850 |
| 122 | Amyloidosis (HP:0011034) | 1.87942382 |
| 123 | Abnormality of the pericardium (HP:0001697) | 1.86930098 |
| 124 | Increased connective tissue (HP:0009025) | 1.86691384 |
| 125 | Increased serum ferritin (HP:0003281) | 1.86546715 |
| 126 | Chest pain (HP:0100749) | 1.86252418 |
| 127 | Gastrointestinal inflammation (HP:0004386) | 1.86215935 |
| 128 | Eosinophilia (HP:0001880) | 1.85819275 |
| 129 | Emphysema (HP:0002097) | 1.85552489 |
| 130 | Epistaxis (HP:0000421) | 1.84800030 |
| 131 | Keratoconjunctivitis (HP:0001096) | 1.84227575 |
| 132 | Hypergammaglobulinemia (HP:0010702) | 1.84139674 |
| 133 | Chronic otitis media (HP:0000389) | 1.83934227 |
| 134 | Chronic diarrhea (HP:0002028) | 1.83361548 |
| 135 | Colitis (HP:0002583) | 1.82539025 |
| 136 | T lymphocytopenia (HP:0005403) | 1.82477272 |
| 137 | Hepatosplenomegaly (HP:0001433) | 1.82253486 |
| 138 | Meningitis (HP:0001287) | 1.82110243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.70769695 |
| 2 | PRPF4B | 3.27260642 |
| 3 | TBK1 | 3.09069187 |
| 4 | TYK2 | 2.92389383 |
| 5 | IRAK3 | 2.80918713 |
| 6 | ERN1 | 2.73728444 |
| 7 | JAK3 | 2.66571219 |
| 8 | MAP4K1 | 2.57303181 |
| 9 | KIT | 2.38672019 |
| 10 | JAK1 | 2.27603847 |
| 11 | IKBKE | 2.27445631 |
| 12 | TXK | 2.25212924 |
| 13 | NEK9 | 2.12262177 |
| 14 | RIPK4 | 2.11865278 |
| 15 | IKBKB | 2.10997675 |
| 16 | TRIB3 | 2.02017596 |
| 17 | IRAK4 | 1.97283300 |
| 18 | TGFBR2 | 1.94965653 |
| 19 | FGFR4 | 1.81558698 |
| 20 | TTN | 1.73344133 |
| 21 | BLK | 1.69713673 |
| 22 | ZAP70 | 1.64456065 |
| 23 | TAOK3 | 1.59839306 |
| 24 | CHUK | 1.50595391 |
| 25 | MAP3K13 | 1.50502607 |
| 26 | FGFR3 | 1.46813054 |
| 27 | CSK | 1.43456450 |
| 28 | BMX | 1.41380102 |
| 29 | EPHB1 | 1.40821872 |
| 30 | PBK | 1.39408288 |
| 31 | BMPR2 | 1.37978860 |
| 32 | RPS6KA4 | 1.36200860 |
| 33 | CAMK1D | 1.35139700 |
| 34 | EPHA3 | 1.33694005 |
| 35 | MAPK7 | 1.33682300 |
| 36 | MST1R | 1.31983711 |
| 37 | SIK1 | 1.31935586 |
| 38 | GRK7 | 1.28713146 |
| 39 | PKN2 | 1.24892638 |
| 40 | CSF1R | 1.24888037 |
| 41 | HCK | 1.23552204 |
| 42 | NME2 | 1.22203419 |
| 43 | PTK6 | 1.20683741 |
| 44 | RIPK1 | 1.20520166 |
| 45 | STK10 | 1.19148600 |
| 46 | CDC42BPA | 1.18977600 |
| 47 | MAPK12 | 1.16115512 |
| 48 | TRPM7 | 1.15568738 |
| 49 | JAK2 | 1.14420709 |
| 50 | PIM2 | 1.13629150 |
| 51 | MYLK | 1.12755457 |
| 52 | CAMKK2 | 1.09946512 |
| 53 | TAOK2 | 1.09684199 |
| 54 | LRRK2 | 1.06648076 |
| 55 | CDK6 | 1.03122744 |
| 56 | PIM1 | 1.02247549 |
| 57 | STK3 | 1.02041060 |
| 58 | ITK | 1.01852904 |
| 59 | LCK | 0.99996676 |
| 60 | MAP2K3 | 0.99851507 |
| 61 | MAP3K3 | 0.98575401 |
| 62 | SYK | 0.95682028 |
| 63 | CDK12 | 0.93114038 |
| 64 | TEC | 0.91190881 |
| 65 | MAPK11 | 0.83438721 |
| 66 | BTK | 0.83172485 |
| 67 | LYN | 0.82781406 |
| 68 | MARK3 | 0.82531001 |
| 69 | PDGFRB | 0.81495523 |
| 70 | PDGFRA | 0.80637175 |
| 71 | KDR | 0.80475919 |
| 72 | MAPK4 | 0.77990652 |
| 73 | MELK | 0.74922202 |
| 74 | EGFR | 0.73144388 |
| 75 | SIK3 | 0.72252394 |
| 76 | ABL1 | 0.70581709 |
| 77 | HIPK2 | 0.70471771 |
| 78 | MAP3K10 | 0.69429242 |
| 79 | CAMK1G | 0.68921108 |
| 80 | MAP3K1 | 0.68328055 |
| 81 | ABL2 | 0.67612181 |
| 82 | FGR | 0.65349267 |
| 83 | DDR2 | 0.65108867 |
| 84 | STK4 | 0.64724539 |
| 85 | LATS1 | 0.64166241 |
| 86 | MOS | 0.58651884 |
| 87 | MATK | 0.55935977 |
| 88 | PDK1 | 0.55778065 |
| 89 | PAK4 | 0.55186914 |
| 90 | NUAK1 | 0.55000603 |
| 91 | RPS6KL1 | 0.52629201 |
| 92 | RPS6KC1 | 0.52629201 |
| 93 | EIF2AK2 | 0.52307675 |
| 94 | IRAK1 | 0.51647269 |
| 95 | GRK6 | 0.51008244 |
| 96 | OBSCN | 0.50740229 |
| 97 | EIF2AK3 | 0.49219520 |
| 98 | FLT3 | 0.48504610 |
| 99 | SIK2 | 0.47829583 |
| 100 | MAP3K5 | 0.47813747 |
| 101 | IGF1R | 0.47110492 |
| 102 | PDPK1 | 0.46287943 |
| 103 | RPS6KA6 | 0.44624161 |
| 104 | MAP3K7 | 0.44330879 |
| 105 | SCYL2 | 0.43669838 |
| 106 | GSK3A | 0.43490439 |
| 107 | STK24 | 0.43162841 |
| 108 | MAP3K11 | 0.41929013 |
| 109 | TGFBR1 | 0.41856702 |
| 110 | PRKCD | 0.40682068 |
| 111 | PRKD2 | 0.39859463 |
| 112 | PRKG2 | 0.39445766 |
| 113 | PRKCQ | 0.39107491 |
| 114 | INSR | 0.38803298 |
| 115 | PRKAA2 | 0.38314646 |
| 116 | WNK1 | 0.38160571 |
| 117 | YES1 | 0.37782988 |
| 118 | MAPKAPK2 | 0.37158862 |
| 119 | PRKCH | 0.36576663 |
| 120 | PIK3CG | 0.36563002 |
| 121 | SGK3 | 0.36271440 |
| 122 | FES | 0.35141304 |
| 123 | CAMKK1 | 0.34028569 |
| 124 | PAK2 | 0.33967754 |
| 125 | NLK | 0.33135084 |
| 126 | FRK | 0.31532051 |
| 127 | DMPK | 0.30953081 |
| 128 | CDK4 | 0.29641286 |
| 129 | ERBB3 | 0.28675956 |
| 130 | ERBB4 | 0.27568966 |
| 131 | MTOR | 0.26453001 |
| 132 | PIK3CA | 0.25569152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.01257479 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.84957194 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.53765762 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.49318229 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.41913604 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33145771 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28799337 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.10861063 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.05834850 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.05210511 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.95377223 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.93079465 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.88995820 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.87292817 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86648324 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.86479313 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.81860247 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69373116 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69144714 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.68137763 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.66939106 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60478799 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.57335912 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56432853 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52868903 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.52734775 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.48242638 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43794227 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43329093 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.41029107 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37433590 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36138823 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35908804 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.31380438 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.27953666 |
| 36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27174319 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26302717 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23689811 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23445915 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.18576727 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 1.15879371 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.12967821 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11279795 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11204408 |
| 45 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10210822 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06674572 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.04702611 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04585021 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02502206 |
| 50 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02312176 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02119196 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99182602 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95985095 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95857929 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.94166847 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93938998 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93893508 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90581096 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86446264 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86074143 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85436472 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84943900 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83724293 |
| 64 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.81050251 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80216796 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77708907 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77445098 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.75442258 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74592502 |
| 70 | Focal adhesion_Homo sapiens_hsa04510 | 0.67748887 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67020934 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.66397766 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66245435 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63860726 |
| 75 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61232988 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60893668 |
| 77 | Bladder cancer_Homo sapiens_hsa05219 | 0.54614945 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54212823 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52323381 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50706431 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49024291 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48403373 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48119602 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47884500 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.47268303 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46954102 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45806149 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45550600 |
| 89 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.45171637 |
| 90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43882018 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.42512608 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41876201 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41535965 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.37874612 |
| 95 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37776796 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37332120 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37073112 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37070315 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36882209 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36522095 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36352925 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.35015653 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33327981 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32568377 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31969587 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31609571 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.31369864 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.30799029 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30705633 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.30680260 |
| 111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.29435277 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29088362 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.28243379 |
| 114 | Lysine degradation_Homo sapiens_hsa00310 | 0.27161711 |

